Keith Haddaway will present on new amendments to Chinese patent law. The program, “2021 Amendments to Chinese patent law—What’s in it for the life sciences?” will discuss the important consequences for life sciences patent practice in China.
While similar to the Hatch-Waxman process, the Chinese law also encompasses biologics and traditional Chinese medicines in addition to small-chemical drugs. Amendments are also directed at extensions of patent terms under particular circumstances. The most striking change is the establishment of a system for resolving patent disputes in the life sciences. This presentation will include a description of the new Chinese system and a comparison to the US system.
Registration for the webinar is complimentary, so sign up today to secure your place.
As always, our webinars are interactive so we encourage you to come armed with questions for our speakers.